Funding AMR research: the UK Research Councils John Savill

Size: px
Start display at page:

Download "Funding AMR research: the UK Research Councils John Savill"

Transcription

1 Funding AMR research: the UK Research Councils John Savill Medical Research Council - UK

2 MRC mission Encourage and support high-quality research with the aim of improving human health. Produce skilled researchers. Advance and disseminate knowledge and technology to improve the quality of life and economic competitiveness in the UK and worldwide. Promote dialogue with the public about medical research.

3 MRC investment in research, 2012/13 MRC research expenditure million in 2012/ m on around 400 programmes in MRC research units and institutes (inc 9.9m on studentships) m on around 1,400 grants to researchers in universities, medical schools and research institutes. 86.1m on studentships and fellowships in universities, medical schools and research institutes.

4 The UK: A rich network of funders and researchers Research community UK Clinical Research Collaboration Learned societies UK Government Departments OSCHR Research Councils NIHR Technology Strategy Board Public Parliamentarians Policy-makers Industry Universities DEFRA International Medical charities Patients and carers NHS

5 AMR research in the UK Growing concern of AMR: a political and societal priority The research councils: broad remits; support AMR across the whole of the research spectrum Research Councils portfolio: ~ 30m per year on AMR

6 What is needed? Collaborative working Coordination of key disciplines Coordinating research funding government and other research funders including industry Ensuring integration with human/animal healthcare UK AMR Funders Forum

7 AMR Funders Forum (AMRFF) Made up of representatives from the research councils, governmental bodies and charities Led and managed by the MRC Has a common vision for AMR research and its implementation Will add value to existing programmes Will coordinate and/or support the initiation of funding and delivery programmes Will raise the profile of the AMR research base in the UK and internationally

8 AMRFF current membership The Biotechnology and Biological Sciences Research Council (BBSRC) DEFRA, the Veterinary Medicines Directorate The Department of Health The Economic and Social Research Council (ESRC) The Engineering and Physical Sciences Research Council (EPSRC) The Food Standards Agency HSC R&D Division, Public Health Agency, Northern Ireland *The Medical Research Council (MRC) National Institute of Health Research (NIHR) The Natural Environment Research Council (NERC) The Science and Technology Facilities Research Council (STFC) The Technology Strategy Board (TSB) The Wellcome Trust

9 Research priorities identified Understanding resistant bacteria in context: from genomic, through to cellular and host pathogen interaction Accelerating therapeutic and diagnostics development: development and revisiting of small molecule antibiotics, new non-small molecule based treatments and diagnostics Understanding real world interactions: how resistant bacteria affect their environments and vice versa. New sources of antibiotics Behaviour and care: behaviour change in human and animal healthcare settings. New business models needed for antibiotics development

10 UK spend on AMR (since 2007) Total funding: 337m Therapeutics 0.6m 26.6m Diagnostics 20.4m Surveillance Transmission Environment 20.6m 68.7m 200m Underpinning Alternatives Optimisation Lead compounds Interventions

11 The breadth of current research Major UK investments: Understanding bacteria: Eg: Centre for Molecular Bacteriology and Infection Technology to reduce infection: Eg: Early Warning Sensing Systems i-sense (EPSRC) Links with industry: Eg: New anti-bacterial to treat MRSA (BBSRC) Environment: Eg: NERC Centre for Ecology and Hydrology: modelling antibiotics usage

12 Current joint initiatives 4 x UKCRC Translational Infection Research Initiative consortia, MRC-led joint initiative University of Oxford, Derrick Crook (genomics to detect transmission) Imperial, Jonathan Friedland (Health Care Associated Infection and AMR) University of Cambridge, Sharon Peacock (MRSA transmission) University of London, Tariq Sadiq (Diagnostics and STIs) Environmental and Social Ecology of Human Infectious Diseases (ESEI) MRC-led, as part of LWEC novel inter-disciplinary approaches to studying the ecology of infectious diseases

13 Cambridge UKCRC Consortium UK MRSA investigation network: a case study English referral network : Donker, Wallinga and Grundmann, PLoS 2012

14 Case study outcomes Whole genome sequencing tools to detect patterns of MRSA transmission Transmission modelling within a hospital and between hospitals UK hospital: Addenbrooke Cambridge Netherlands hospital: University Medical hospital Groningen MRSA rate reflects connectivity of the hospital more movement and referral between hospitals, less control of MRSA Hospitals that share >50 patients / year share homogenous MRSA

15 Developing international links - highlights JPIAMR: MRC lead on behalf of the UK Canada: 2 x UK-CIHR Partnership on antimicrobial resistance consortia University of Cardiff (Tim Walsh) and Canada (Gary Dmitrienko) University of Warwick (Chris Dowson) and Canada (Anthony Clarke) BBSRC partner of Global Strategic Alliance for coordination of research on major infectious diseases of animals and zoonoses Currently identifying international opportunities via RCUK offices in China, India and USA

16 Providing excellent underpinning resources Medical Bioinformatics call Universities of Warwick and Swansea: The MRC Consortium for Medical Microbial Bioinformatics (wide range of research including AMR surveillance and data sharing) The Farr Institute: for health informatics research Linking with Industry IMI: the MRC represents the UK Revisiting old compounds with new science TSB/MRC Biomedical Catalyst fund Eg: The use of light activated antimicrobials to prevent catheter related infection. Ivan Parkin, UCL

17 The next steps Develop new research opportunities Academic/private sector International Develop new treatments Develop new diagnostics Develop surveillance systems Uptake by human/animal healthcare providers

Strategic priority for AMR

Strategic priority for AMR Strategic priority for AMR Transforming our response to drug resistant infections Ghada Zoubiane PhD Science Lead Drug-Resistant Infections priority programme Joint Programming Initiative on AMR MB meeting

More information

Research and development case study. Human health research

Research and development case study. Human health research Research and development case study Human health research November 2017 Introduction This case study on human health research is one of a series that we have developed to support and complement our published

More information

Translational Research

Translational Research Translational Research Paddy Johnston Chair, MRC Translational Research Overview Group October 2012 Translational Research Strategy and its delivery To accelerate patient benefit and increase economic

More information

Healthcare Technologies Strategy

Healthcare Technologies Strategy ENGINEERING AND PHYSICAL SCIENCES RESEARCH COUNCIL Healthcare Technologies Strategy TOWN MEETING, APRIL 14 th 2015 Aug 2014 Engineering and Physical Sciences Research Council Healthcare Technologies 29%of

More information

AMR and EPSRC AMR Networks Meeting, Sheffield, Sept 16 Christina Turner and Stephanie Newland

AMR and EPSRC AMR Networks Meeting, Sheffield, Sept 16 Christina Turner and Stephanie Newland AMR and EPSRC AMR Networks Meeting, Sheffield, Sept 16 Christina Turner and Stephanie Newland Overview AMR at RCUK and EPSRC Annual Monitoring Funding RCUK AMR Initiative Unless we take global action,

More information

MRC s Pathways to Translation.. Louise Jones, Feb 13 th 2015, LSTM

MRC s Pathways to Translation.. Louise Jones, Feb 13 th 2015, LSTM MRC s Pathways to Translation.. Louise Jones, Feb 13 th 2015, LSTM MRC Remit and Partners MRC: basic research to early clinical trials Underpinning and aetiological Prevention Detection and diagnosis Treatment

More information

MRC Translational Funding

MRC Translational Funding MRC Translational Funding Dr Jo Latimer- 29 February 2016 Medical Research Council MRC: Leading & Partnering Research Dedicated to improving human health through the best scientific research. Established

More information

Royal Society of Chemistry Response to the House of Commons Science and Technology Committee Call For Evidence: Antimicrobial Resistance

Royal Society of Chemistry Response to the House of Commons Science and Technology Committee Call For Evidence: Antimicrobial Resistance Royal Society of Chemistry Response to the House of Commons Science and Technology Committee Call For Evidence: Antimicrobial Resistance The Royal Society of Chemistry is the world s leading chemistry

More information

UK AMR Diagnostics Collaborative:

UK AMR Diagnostics Collaborative: UK AMR Diagnostics Collaborative: Maximising the use of diagnostic technology to tackle AMR Fiona Carragher FRCPath @DepCSOFiona Deputy Chief Scientific Officer for England england.amrdiagnostics@nhs.net

More information

Enabling the adoption of new diagnostics within the UK healthcare system:

Enabling the adoption of new diagnostics within the UK healthcare system: Enabling the adoption of new diagnostics within the UK healthcare system: The key role of diagnostics in the AMR challenge Fiona Carragher FRCPath @DepCSOFiona Deputy Chief Scientific Officer for England

More information

The role of PHE s AMRHAI Reference Unit

The role of PHE s AMRHAI Reference Unit The role of PHE s AMRHAI Reference Unit Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit Crown copyright What does AMRHAI offer? Susceptibility

More information

The Wellcome Trust. Research Support and Strategy in Epidemiology. Monday, 22 September Dr Alan Doyle

The Wellcome Trust. Research Support and Strategy in Epidemiology. Monday, 22 September Dr Alan Doyle The Wellcome Trust Research Support and Strategy in Epidemiology Monday, 22 September 2008 Dr Alan Doyle The Wellcome Trust an independent researchfunding charity established 1936 funded from private endowment

More information

Research Councils UK Energy Programme

Research Councils UK Energy Programme Research Councils UK Energy Programme Kathryn Magnay, Head RCUK Energy Programme For a Low Carbon Energy Future The Research Councils Research Councils UK (RCUK) are responsible for investing public money

More information

MRC Stratified Medicine Initiative

MRC Stratified Medicine Initiative MRC Stratified Medicine Initiative Jonathan Pearce Medical Research Council, Translational Programme Manager Pharmacogenetics and Stratified Medicine Network Conference : 14 th January 2015 Stratified

More information

Improving Pa-ent Outcomes with Research: The Appliance of Science NIHR UCL Hospitals Biomedical Research Centre

Improving Pa-ent Outcomes with Research: The Appliance of Science NIHR UCL Hospitals Biomedical Research Centre Improving Pa-ent Outcomes with Research: The Appliance of Science NIHR UCL Hospitals Biomedical Research Centre Bryan Williams MD FRCP FESC FAHA Professor of Medicine and BRC Director 29/08/2013 Creating

More information

BIOMEDICAL RESEARCH CENTRES

BIOMEDICAL RESEARCH CENTRES Introduction BIOMEDICAL RESEARCH CENTRES The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. This document sets out how the

More information

MINUTES. UK CLINICAL RESEARCH COLLABORATION BOARD MEETING 14 May 2015

MINUTES. UK CLINICAL RESEARCH COLLABORATION BOARD MEETING 14 May 2015 MINUTES UK CLINICAL RESEARCH COLLABORATION BOARD MEETING 14 May 2015 Present Members Minutes of the meeting held on 14 May 2015, Rooms 1&2, 13th Floor, MRC, One Kemble Street, London WC2B 4TS Sir John

More information

A new vision for AMR innovation to support medical care

A new vision for AMR innovation to support medical care APRIL 2019 A new vision for AMR innovation to support medical care About the BEAM Alliance The BEAM Alliance (Biotech companies from Europe innovating in Anti-Microbial resistance research) represents

More information

Research Councils UK Energy Programme

Research Councils UK Energy Programme Research Councils UK Energy Programme For a Low Carbon Energy Future Jason Green Treasury ETI BIS TSB RCUK AHRC BBSRC ESRC EPSRC MRC NERC STFC Cross Council Energy Programme Treasury ETI BIS TSB RCUK AHRC

More information

NIHR at 10: Wessex. Professor Chris Whitty Chief Scientific Adviser Department of Health

NIHR at 10: Wessex. Professor Chris Whitty Chief Scientific Adviser Department of Health NIHR at 10: Wessex Professor Chris Whitty Chief Scientific Adviser Department of Health Building on 10 remarkable years The extraordinary advances in health are based on evidence and science, properly

More information

Personalized. Health in Canada

Personalized. Health in Canada Personalized Health in Canada Canadian Institutes of Health Research Personalized Medicine Signature Initiative 2010-2013 0 Dr. Morag Park CIHR Institute of Cancer Research Dr. Paul Lasko CIHR Institute

More information

Antimicrobial Drug Discovery

Antimicrobial Drug Discovery Antimicrobial Drug Discovery Following publication of the Statement Antimicrobial drug discovery: greater steps ahead (http://www.easac.eu/home/reports and statements/detailview/article/antimicrobia.html),

More information

The Innovate UK response to the Innovative Medicines Initiative consultation Facilitating the translation of advanced therapies to patients in Europe

The Innovate UK response to the Innovative Medicines Initiative consultation Facilitating the translation of advanced therapies to patients in Europe The Innovate UK response to the Innovative Medicines Initiative consultation Facilitating the translation of advanced therapies to patients in Europe Innovate UK and ATMP background 1. Innovate UK is the

More information

TRANSLATIONAL RESEARCH PARTNERSHIPS

TRANSLATIONAL RESEARCH PARTNERSHIPS TRANSLATIONAL RESEARCH PARTNERSHIPS Introduction The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. NIHR Translational Research

More information

Delivering the NIHR Central Commissioning Facility

Delivering the NIHR Central Commissioning Facility Delivering the NIHR Central Commissioning Facility About the NIHR The National Institute for Health Research is funded through the Department of Health to improve the health and wealth of the nation through

More information

A whole-system approach to delivering personalised medicine and health in Leeds. Mike Messenger

A whole-system approach to delivering personalised medicine and health in Leeds. Mike Messenger A whole-system approach to delivering personalised medicine and health in Leeds Mike Messenger Capacity and Resource What is the challenge? In 2016, we face the most significant challenges for a generation.

More information

Research Councils UK Energy Programme

Research Councils UK Energy Programme Research Councils UK Energy Programme Valuing Natural Capital in Low Carbon Energy Pathways Programme - Ideas Brokerage Workshop 21 st - 22 nd July 2014 Eloise Meller, ESRC For a Low Carbon Energy Future

More information

UK Molecular Pathology Landscape

UK Molecular Pathology Landscape UK Molecular Pathology Landscape Jonathan Pearce Medical Research Council, Translational Programme Manager Novel Markers and Technology: 12 October 2015 Stratified medicine has the potential to deliver

More information

Longitudinal Population Studies Strategy

Longitudinal Population Studies Strategy Longitudinal Population Studies Strategy Wellcome s Longitudinal Population Studies Working Group July 2017 Executive summary Opportunity Longitudinal population studies (LPS), which include cohorts, panel

More information

Biomedical & Health Research (BHR) Strategy

Biomedical & Health Research (BHR) Strategy Biomedical & Health Research (BHR) Strategy Vision To be internationally recognised for our research in Biomedicine and Health, addressing global grand challenges through distinctive, focussed, world-leading

More information

LEEDS CITY REGION DIAGNOSTICS AND PERSONALISED MEDICINE

LEEDS CITY REGION DIAGNOSTICS AND PERSONALISED MEDICINE LEEDS CITY REGION DIAGNOSTICS AND PERSONALISED MEDICINE LEEDS CITY REGION S STRENGTHS: LIFE SCIENCES - THE OPPORTUNITY TAP INTO WORLD-LEADING RESEARCH FROM LEEDS CITY REGION S UNIVERSITIES ACCELERATING

More information

Cancer Research UK submission to House of Lords Science and Technology Committee inquiry on Scientific Infrastructure. June 2013

Cancer Research UK submission to House of Lords Science and Technology Committee inquiry on Scientific Infrastructure. June 2013 Cancer Research UK submission to House of Lords Science and Technology Committee inquiry on Scientific Infrastructure June 2013 1. Every year around 300,000 people are diagnosed with cancer in the UK.

More information

Research Strategy Delivering internationally excellent research for a healthy, safe and sustainable society

Research Strategy Delivering internationally excellent research for a healthy, safe and sustainable society Research Strategy 2016-2018 Delivering internationally excellent research for a healthy, safe and sustainable society Mission The College of Biomedical and Life Sciences aims to deliver internationally

More information

The Innovative Medicines Initiative Europe s partnership for health. Tek-Ang LIM, 20 June 2018, Brussels

The Innovative Medicines Initiative Europe s partnership for health. Tek-Ang LIM, 20 June 2018, Brussels The Innovative Medicines Initiative Europe s partnership for health Tek-Ang LIM, 20 June 2018, Brussels 10 YEARS OF LIGHTING THE WAY IMI Why Europe s partnership for health? Because despite decades of

More information

NIHR TRANSLATIONAL RESEARCH COLLABORATION INFLAMMATORY RESPIRATORY DISEASE

NIHR TRANSLATIONAL RESEARCH COLLABORATION INFLAMMATORY RESPIRATORY DISEASE NIHR TRANSLATIONAL RESEARCH COLLABORATION INFLAMMATORY RESPIRATORY DISEASE EXPERTISE AND CAPABILITIES The TRC in Inflammatory Respiratory Disease provides cutting-edge expertise in the development of exploratory

More information

Medicines for Children Research Network. Consumer Strategy

Medicines for Children Research Network. Consumer Strategy Medicines for Children Research Network Consumer Strategy 2012-2015 NIHR-MCRN Strategy for Consumer Involvement 2012-2015 1. Introduction and background Consumer involvement is a central thread running

More information

Articles. Funding JPIAMR and the European Commission. Copyright Kelly et al. Open Access article distributed under the terms of CC BY.

Articles. Funding JPIAMR and the European Commission. Copyright Kelly et al. Open Access article distributed under the terms of CC BY. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis Ruth Kelly, Ghada Zoubiane,

More information

Theme 2 Workshop: Accelerating therapeutic and diagnostics development

Theme 2 Workshop: Accelerating therapeutic and diagnostics development Theme 2 Workshop: Accelerating therapeutic and diagnostics development Workshop Report... 2 1. Background... 2 2. Format of the Workshops... 2 3. Workshop presentations... 3 4. Breakout sessions and group

More information

Australian Medical Research and Innovation Priorities Determination 2018

Australian Medical Research and Innovation Priorities Determination 2018 Australian Medical Research and Innovation Priorities 2018 2020 Determination 2018 I, Ian Frazer, Chair of the Australian Medical Research Advisory Board, make the following instrument on behalf of the

More information

The Impact of Translational Research

The Impact of Translational Research The Impact of Translational Research Chris Watkins and Ian Viney Medical Research Council October 2016 Open Council Translation Across the MRC Portfolio MRC support for translational medicine Proportion

More information

Sustainable Health Care Systems: Research and Innovation

Sustainable Health Care Systems: Research and Innovation Backgroundpaper B7-Communiqué Sustainable Health Care Systems: Research and Innovation Version II BDI, BUSINESSEUROPE Canadian Chamber of Commerce CBI CONFIDUSTRIA Keidanren MEDEF US Chamber of Commerce

More information

1.0 Background to the organisation

1.0 Background to the organisation 1.0 Background to the organisation The National University of Ireland Galway, the Royal College of Surgeons in Ireland, University College Cork, University College Dublin and Trinity College and their

More information

The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence

The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence Prof Mark Caulfield FMedSci Chief Scientist for Genomics England Barts Heart Centre William Harvey Research Institute Queen Mary

More information

Summary of MRC Unit and Institute Quinquennial Reviews

Summary of MRC Unit and Institute Quinquennial Reviews Summary of MRC Unit and Institute Quinquennial Reviews The MRC carries out scientific reviews in order to be assured of: the overall quality, impact, and productivity (past and future potential) of the

More information

Med-tech and diagnostic device pathways in Newcastle

Med-tech and diagnostic device pathways in Newcastle Med-tech and diagnostic device pathways in Newcastle Andrew Sims Medical Physics Newcastle upon Tyne Hospitals NHS Foundation Trust 12/07/2016 AHSN Stakeholder Engagement Meeting 1 Introduction Section

More information

Meeting Opening MRC Molecular Pathology Review NIHR support for molecular pathology Innovate UK Precision Medicine Catapult

Meeting Opening MRC Molecular Pathology Review NIHR support for molecular pathology Innovate UK Precision Medicine Catapult Agenda Agenda 10:30 Meeting Opening 10:40 MRC Molecular Pathology Review Professor Sir Robert Lechler (King s College London and Chair of Review Steering Group) 10:55 NIHR support for molecular pathology

More information

Research Councils UK. The Future of RCUK/ EPSRC Research Funding. Dr Clive Hayter, Associate Director Research Programmes, EPSRC

Research Councils UK. The Future of RCUK/ EPSRC Research Funding. Dr Clive Hayter, Associate Director Research Programmes, EPSRC Research Councils UK The Future of RCUK/ EPSRC Research Funding Dr Clive Hayter, Associate Director Research Programmes, EPSRC Spending Review Allocation (1) Spending Review covers the period 2011/12 2014/15

More information

Moving towards delivering precision medicine in sepsis

Moving towards delivering precision medicine in sepsis Moving towards delivering precision medicine in sepsis Paul Dark Professor of Critical Care Medicine, Division of Infection and Immunity, University of Manchester NIHR CRN National Specialty Lead (Critical

More information

To identify the key research questions in greenhouse gas removal from the atmosphere in the remits of the organising bodies.

To identify the key research questions in greenhouse gas removal from the atmosphere in the remits of the organising bodies. Greenhouse Gas Removal from the Atmosphere 1. Announcement of Workshop London, 28 April 2016 The deadline for applications is 16:00 on Monday 11 th April 2016. Applications received after this time will

More information

Conference Exhibitors

Conference Exhibitors Conference Exhibitors CSM Executive and the 2018 Manitoba Local Organizing Committee would like to thank the following organizations for exhibiting and supporting the Canadian Society of Microbiologists

More information

The International Consortium for Personalised Medicine

The International Consortium for Personalised Medicine The International Consortium for Personalised Medicine Mairead O Driscoll Alliance for Biomedical Research in Europe, 8 November 2017 Personalised Medicine A definition Characterisation of individuals

More information

University of Cambridge Wellcome Trust. Senior Internships for Interdisciplinary Research

University of Cambridge Wellcome Trust. Senior Internships for Interdisciplinary Research University of Cambridge Wellcome Trust Senior Internships for Interdisciplinary Research Introduction and aims of the Scheme Applications are invited for the next round of University of Cambridge Wellcome

More information

Academic Medical Bacteriology A 2/7/01 2:40 pm Page 3. Academic Medical Bacteriology in the 21st Century

Academic Medical Bacteriology A 2/7/01 2:40 pm Page 3. Academic Medical Bacteriology in the 21st Century Academic Medical Bacteriology A 2/7/01 2:40 pm Page 3 Academic Medical Bacteriology in the 21st Century July 2001 The Academy of Medical Sciences The Academy of Medical Sciences was established in 1998

More information

ECO-PHARMACO- STEWARDSHIP (EPS) PILLAR 1 - RESEARCH & DEVELOPMENT: INTELLIGENCE-LED ASSESSMENT OF PHARMACEUTICALS IN THE ENVIRONMENT (ipie)

ECO-PHARMACO- STEWARDSHIP (EPS) PILLAR 1 - RESEARCH & DEVELOPMENT: INTELLIGENCE-LED ASSESSMENT OF PHARMACEUTICALS IN THE ENVIRONMENT (ipie) ECO-PHARMACO- STEWARDSHIP (EPS) PILLAR 1 - RESEARCH & DEVELOPMENT: INTELLIGENCE-LED ASSESSMENT OF PHARMACEUTICALS IN THE ENVIRONMENT (ipie) PILLAR 1 - RESEARCH & DEVELOPMENT: INTELLIGENCE-LED ASSESSMENT

More information

A2 Drive new ways of working, especially data-intensive/rich, multidisciplinary bioscience (2.1.2)

A2 Drive new ways of working, especially data-intensive/rich, multidisciplinary bioscience (2.1.2) A: BBSRC sustaining world class bioscience in the UK - maintaining excellence in bioscience A1 Continue to fund highest quality, Help retain UK s world-leading position fundamental bioscience (Pervasive)

More information

LONG-TERM BENEFITS FROM RESEARCH INTO STREPTOMYCES BACTERIA

LONG-TERM BENEFITS FROM RESEARCH INTO STREPTOMYCES BACTERIA LONG-TERM BENEFITS FROM RESEARCH INTO STREPTOMYCES BACTERIA Many of the most important antibiotics used in hospitals around the world come from Streptomyces bacteria. Recent discoveries have shown that

More information

The NIHR. NIHR: health research in Professor Stephen Smye Specialty Cluster Lead, NIHR CRN, King s College London. Clinical Research Network

The NIHR. NIHR: health research in Professor Stephen Smye Specialty Cluster Lead, NIHR CRN, King s College London. Clinical Research Network The NIHR NIHR: health research in 2030 Professor Stephen Smye Specialty Cluster Lead, NIHR CRN, King s College London Why? https://www.bhf.org.uk/publications/statistics/ trends-in-coronary-heart-disease-1961-2011

More information

Rare diseases in the 7th EU Framework Programme for Research and Technological Development

Rare diseases in the 7th EU Framework Programme for Research and Technological Development Rare diseases in the 7th EU Framework Programme for Research and Technological Development Manuel Hallen, MD Head of Unit Medical & Public Health Research DG Research European Commission 1 The role of

More information

SSPPS STRATEGIC PLAN. Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice. April 30, Overview

SSPPS STRATEGIC PLAN. Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice. April 30, Overview SSPPS STRATEGIC PLAN Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice April 30, 2012 Overview Here we present the 2012-2017 strategic plan for the Skaggs School of Pharmacy

More information

Global Antibiotic R&D Partnership A joint WHO/DNDi initiative. Overview. Dr Manica Balasegaram GARDP Director

Global Antibiotic R&D Partnership A joint WHO/DNDi initiative. Overview. Dr Manica Balasegaram GARDP Director Global Antibiotic R&D Partnership A joint WHO/DNDi initiative Overview Dr Manica Balasegaram GARDP Director What is GARDP? The Global Antibiotic Research and Development Partnership is a not-for-profit

More information

Supporting efficient and effective clinical research in the UK

Supporting efficient and effective clinical research in the UK Supporting efficient and effective clinical research in the UK National Institute for Health Research 10 years of delivering health and care research for the nation HRB CRCI Launch Dr Matthew Hallsworth

More information

The Genomic Transformation of Health

The Genomic Transformation of Health The Genomic Transformation of Health or: an introduction to the potential of genomics in healthcare Dr Tom Connor School of Biosciences and Systems Immunity University Research Institute Cardiff University

More information

BEAM Alliance urges G20 support to fight deadly superbugs

BEAM Alliance urges G20 support to fight deadly superbugs Press Release BEAM Alliance urges G20 support to fight deadly superbugs At the Hamburg G20 summit, political leaders will speak about a growing global health threat - antibiotic resistance - which causes

More information

International Cooperation in Health Research and Life Sciences Modalities and Topics of next Call

International Cooperation in Health Research and Life Sciences Modalities and Topics of next Call 1 International Cooperation in Health Research and Life Sciences Modalities and Topics of next Call Dr Gianpietro van de Goor Directorate Health, DG Research European Commission Open Information Day Brussels,

More information

2016 EUROPE NORDIC U.S. SYMPOSIUM. New Frontiers in Antibacterial Resistance Research

2016 EUROPE NORDIC U.S. SYMPOSIUM. New Frontiers in Antibacterial Resistance Research 2016 EUROPE NORDIC U.S. SYMPOSIUM New Frontiers in Antibacterial Resistance Research January 20-21, 2016 Venue: Karolinska institutet Stockholm, Sweden Objectives: Antibacterial resistance is accelerating

More information

Appointment of: Programme leaders for the UK Dementia Research Institute

Appointment of: Programme leaders for the UK Dementia Research Institute Appointment of: Programme leaders for the UK Dementia Research Institute Contents 3 About the UK Dementia Research Institute 4 Strategic vision 6 About the centres 8 Programme leader profile - UK DRI Professor

More information

CONSTITUTION OF THE GLOBAL ALLIANCE FOR GENOMICS AND HEALTH. Adopted, 2014

CONSTITUTION OF THE GLOBAL ALLIANCE FOR GENOMICS AND HEALTH. Adopted, 2014 CONSTITUTION OF THE GLOBAL ALLIANCE FOR GENOMICS AND HEALTH Adopted, 2014 This Constitution sets forth the mission, objectives, and structure of the Global Alliance for Genomics and Health (Global Alliance).

More information

Russell Group input to the 2013 Triennial Review of the Research Councils

Russell Group input to the 2013 Triennial Review of the Research Councils Russell Group input to the 2013 Triennial Review of the Research Councils Summary The broad objectives for the Research Councils remain highly relevant and still need to be delivered. Any significant disruption

More information

WHO draft outline of global action plan on antimicrobial resistance

WHO draft outline of global action plan on antimicrobial resistance WHO draft outline of global action plan on antimicrobial resistance Response by the Wellcome Trust Key Points Antimicrobial resistance (AMR) is a global health crisis which no government can tackle on

More information

Diagnostics gathering intelligence to fight antimicrobial resistance

Diagnostics gathering intelligence to fight antimicrobial resistance Diagnostics gathering intelligence to fight antimicrobial resistance Arjon van Hengel European Commission DG Research and Innovation, Health Directorate Unit "Fighting Infectious Diseases and Advancing

More information

Course outlines for senior Microbiology and Virology units of study within the Bachelor of Medical Science Last updated 18 November 2006

Course outlines for senior Microbiology and Virology units of study within the Bachelor of Medical Science Last updated 18 November 2006 Course outlines for senior Microbiology and Virology units of study within the Bachelor of Medical Science Last updated 18 November 2006 These course outlines are a guide only. They are provided for the

More information

Independent Member of the HMG Strategic Coherence of ODA-funded Research (SCOR) Board. Information pack for applicants

Independent Member of the HMG Strategic Coherence of ODA-funded Research (SCOR) Board. Information pack for applicants Independent Member of the HMG Strategic Coherence of ODA-funded Research (SCOR) Board Closing date for applications: 2nd of March 2018 Information pack for applicants Applications processed by the UK Collaborative

More information

The role of the Clinical Trials Unit Emma Hall PhD CStat Institute of Cancer Research Clinical Trials and Statistics Unit (ICR-CTSU)

The role of the Clinical Trials Unit Emma Hall PhD CStat Institute of Cancer Research Clinical Trials and Statistics Unit (ICR-CTSU) in partnership with The role of the Clinical Trials Unit Emma Hall PhD CStat Institute of Cancer Research Clinical Trials and Statistics Unit (ICR-CTSU) CTRad Clinical Trials Workshop 14/10/2014 What is

More information

State strategies for bioinformatics in BRICs and the UK. Professor Brian Salter

State strategies for bioinformatics in BRICs and the UK. Professor Brian Salter State strategies for bioinformatics in BRICs and the UK Professor Brian Salter This new facility is the embodiment of our investment in big data and bioinformatics. We are not only ensuring that people

More information

Programme Manager GROW Colombia JOB VACANCY

Programme Manager GROW Colombia JOB VACANCY Programme Manager GROW Colombia JOB VACANCY Job details Salary: 39,150-47,850 Post No: 1003398 Contract length: 46 months Department: Organisms & Ecosystems Opening date: 22 January 2018 Closing date:

More information

Consultation on a draft Global action plan to address antimicrobial resistance

Consultation on a draft Global action plan to address antimicrobial resistance Consultation on a draft Global action plan to address antimicrobial resistance The questionnaire is divided into four sections. The questions are broadly framed and intended to give you the opportunity

More information

UK Government Approach to Synthetic Biology. Adrian Smith DG Science and Research

UK Government Approach to Synthetic Biology. Adrian Smith DG Science and Research UK Government Approach to Synthetic Biology Adrian Smith DG Science and Research UK Research Framework Funding approach is through arm s length agencies Government sets overall funding strategy Funding

More information

House of Commons Science and Technology Committee: Inquiry on clinical trials and disclosure of data

House of Commons Science and Technology Committee: Inquiry on clinical trials and disclosure of data House of Commons Science and Technology Committee: Inquiry on clinical trials and disclosure of data Evidence submitted by the Medical Research Council, 26 February 2013 Introduction 1. The Medical Research

More information

Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development

Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development 23 November 2009 Sharon F. Terry, MA President & CEO, Genetic Alliance Executive Director, PXE International

More information

Introductory guide to understanding impact

Introductory guide to understanding impact Introductory guide to understanding impact MVLS impact vision MVLS believes that all excellent research can achieve impact making a constructive difference in some way and at some time, that will ultimately

More information

The Wellcome Trust. FundERS rd Sept 2015

The Wellcome Trust. FundERS rd Sept 2015 The Wellcome Trust FundERS 2015 23 rd Sept 2015 Introduction Our History The Wellcome Trust was set up in 1936 under the will of Sir Henry Wellcome, who vested the entire share of his pharmaceutical company,

More information

Supplementary Materials for

Supplementary Materials for www.sciencetranslationalmedicine.org/cgi/content/full/6/242/242cm6/dc1 Supplementary Materials for Sandbox: Building and Sharing Resources This PDF file includes: Mark David Lim E-mail: mlim@fastercures.org

More information

Mapping the Landscape of UK Health Data Research & Innovation

Mapping the Landscape of UK Health Data Research & Innovation Mapping the Landscape of UK Health Data Research & Innovation A snapshot of activity in 2017 Dr Ekaterini Blaveri October 2017 CONTENTS Foreword 5 1. Background to this review 7 1.1. Aims 8 1.2. Scope

More information

Facilitating Antibacterial Drug Development Outlining the Path Forward

Facilitating Antibacterial Drug Development Outlining the Path Forward Facilitating Antibacterial Drug Development Outlining the Path Forward Helen Boucher, MD FIDSA FACP Division of Infectious Diseases and Geographic Medicine Tufts Medical Center Tufts University School

More information

EU support for Health Research from FP6 to FP7

EU support for Health Research from FP6 to FP7 EU support for Health Research from FP6 to FP7 Stéphane Hogan Head of Biotechnology Unit Directorate for Health Research DG Research - European Commission Valencia - 15 September 2006 EU research programmes

More information

Nordic Common Strengths and Future Potential in the Field of Personalised Medicine

Nordic Common Strengths and Future Potential in the Field of Personalised Medicine Nordic Common Strengths and Future Potential in the Field of Personalised Medicine NOS-M Workshop 23rd November 2016 Stockholm Waterfront Johan Nilsson Coordinator Medicine and Health Swedish Research

More information

Articles. Funding JPIAMR and the European Commission. Copyright Kelly et al. Open Access article distributed under the terms of CC BY.

Articles. Funding JPIAMR and the European Commission. Copyright Kelly et al. Open Access article distributed under the terms of CC BY. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis Ruth Kelly, Ghada Zoubiane,

More information

Webinar IMI2 Call 13 Support and coordination action for the projects of the neurodegeneration area of the Innovative Medicines Initiative

Webinar IMI2 Call 13 Support and coordination action for the projects of the neurodegeneration area of the Innovative Medicines Initiative Webinar IMI2 Call 13 Support and coordination action for the projects of the neurodegeneration area of the Innovative Medicines Initiative 27.11.2017 15:00 CET Agenda How to use GoToWebinar Catherine Brett,

More information

Scottish Microbiology & Virology Network (SMVN)

Scottish Microbiology & Virology Network (SMVN) Scottish Microbiology & Virology Network (SMVN) Annual Workplan 2017-2018 Version 1.0 26 May 2017 Page 1 of 10 SMVN HIGH PRIORITY OVERVIEW The highest priority activities of the SMVN are summarised below.

More information

Antimicrobial resistance: environments, evolution and transmission. Workshop series summary

Antimicrobial resistance: environments, evolution and transmission. Workshop series summary Antimicrobial resistance: environments, evolution and transmission Networking workshops for researchers Workshop series summary Charles Darwin House, London, 25 June 2015 Discovery Centre for Translational

More information

The Integrated Biomedical Sciences Graduate Program

The Integrated Biomedical Sciences Graduate Program The Integrated Biomedical Sciences Graduate Program at the university of notre dame Cutting-edge biomedical research and training that transcends traditional departmental and disciplinary boundaries to

More information

Infectious Diseases Institute Faculty Hires See below for research interests, areas of expertise and contact information

Infectious Diseases Institute Faculty Hires See below for research interests, areas of expertise and contact information Infectious Diseases Institute Faculty Hires See below for research interests, areas of expertise and contact information Matt Anderson, Ph.D. Anderson.3196@osu.edu Microbial Communities, Host Defense and

More information

LABORATORY TRAINING LOGBOOK

LABORATORY TRAINING LOGBOOK REGISTRATION TRAINING PORTFOLIO FOR THE IBMS CERTIFICATE OF COMPETENCE LABORATORY TRAINING LOGBOOK Version 4.1 www.ibms.org Trainee record details Registration Training Portfolio Case No: Surname: First

More information

Call Details. Introduction of DBT-BIRAC Joint call:

Call Details. Introduction of DBT-BIRAC Joint call: Call Details Antimicrobial resistance (AMR) is one of the major threats to human health in the 21 st century, with some bacterial pathogens acquiring resistance to all clinically available antibiotics.

More information

BOARD PAPER - NHS ENGLAND. Purpose of Paper: To inform the Board of the development of an NHS England Personalised Medicine Strategy.

BOARD PAPER - NHS ENGLAND. Purpose of Paper: To inform the Board of the development of an NHS England Personalised Medicine Strategy. Paper: PB.24.09.15/05 Title: Personalised Medicine Strategy. From: Sir Bruce Keogh, National Medical Director. BOARD PAPER - NHS ENGLAND Purpose of Paper: To inform the Board of the development of an NHS

More information

Innovative Medicines Initiative:

Innovative Medicines Initiative: Innovative Medicines Initiative: Opportunities for local players to become important parts of multicountry pharma innovation Nathalie Serigneuret 4 March 2015 Clinical Trials Conference 2015, Budapest

More information

Illustration inspired by the work of John Maynard Keynes Springer Nature Nano/AdisInsight. Daria Iovcheva November, 2017

Illustration inspired by the work of John Maynard Keynes Springer Nature Nano/AdisInsight. Daria Iovcheva November, 2017 Illustration inspired by the work of John Maynard Keynes Springer Nature Nano/AdisInsight Daria Iovcheva November, 2017 1 Contents 1.0 About Springer Nature and our platforms 2.0 Nature Research Journals:

More information

Our Research Strategy

Our Research Strategy Our Research Strategy 2014-2017 Introduction Kidney Research UK has a 52-year legacy in funding excellent research into all aspects of kidney diseases and disorders. Each year over 3.7 million 1 new investments

More information

The interplay between AMR surveillance and science Report of JPIAMR workshop October 2016, The Research Council of Norway, Oslo, Norway

The interplay between AMR surveillance and science Report of JPIAMR workshop October 2016, The Research Council of Norway, Oslo, Norway The interplay between AMR surveillance and science Report of JPIAMR workshop 12.-13. October 2016, The Research Council of Norway, Oslo, Norway Table of contents List of participants... 1 Abbreviations...

More information

EU Big Data Initiatives

EU Big Data Initiatives European Network of Excellence for Big Data in Hematology, consisting of 51 partners from 11 countries. Aliki Taylor, HARMONY Alliance Partner Director Global Health Outcomes, Takeda EU Big Data Initiatives

More information